Poslední aktualizace :
08/05/2024
Vasodilatans   Alprostadil  
Injekce
Stabilita roztoků Stabilita směsí Faktory ovlivňující stabilitu Kompatibilita Způsoby aplikace Odkazy Pdf
   Chemický vzorec  

Obchodní název   Obchodní název     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Alfaprostin Egypt
Alistint Peru
Alpros Turecko
Alprostadil äpanÏlsko, Argentina, Chile, Ekvádor, Kanada, Malajsie, NÏmecko, Peru, Rumunsko, Turecko, USA
Alprostapint Argentina, Ekvádor, Kolumbie, MaÔarsko, Peru, Rakousko
Alprostar Itálie
Aplicav BrazÌlie
Cardiobon Argentina, Peru
Caverject äpanÏlsko, Belgie, BrazÌlie, Dánsko, Francie, Itálie, Jihoafrická republika, Kanada, Norsko, Polsko, Portugalsko, Rakousko, Slovinsko, Švédsko, Švýcarsko, Turecko, USA, Velká Británie
Edex Francie
Liple Japonsko
Minprog NÏmecko, Rakousko
Ostapint Mexiko, Peru
Palux Japonsko
Pridax äpanÏlsko, NÏmecko, Rakousko, Rumunsko
Prolisina VR Argentina
Prostandin Japonsko
Prostavasin Egypt, Írán, Itálie, Lucembursko, MaÔarsko, NÏmecko, Polsko, Rakousko
Prostin VR Austrálie, Belgie, Dánsko, Finsko, Írán, Itálie, Kanada, Lucembursko, Malajsie, MaÔarsko, Nizozemsko, Norsko, Polsko, Portugalsko, Saúdská Arábie, Švýcarsko, USA, Velká Británie, Venezuela, ÿecko
Prostine VR Francie
Vasaprostan Rumunsko
Odkazy   Injekce   Odkazy : Alprostadil  
Typ Uveřejnění
1072 Noviny Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA.
Compatibility of levofloxacin with 34 medications during simulated Y-site administration.
Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1899 Noviny Trissel LA, Zhang Y.
Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction.
Int J Pharm Compound 2004 ; 8, 3: 231-235.
2003 Noviny Paul M, Razzouq N, Tixier G, Astier A.
Stability of prostaglandin E1 (PGE1) in aqueous solutions.
EJHP Science 2005 ; 2: 31-36.
2090 Noviny Pere H, Chasse V, Forest JM, Hildgen P.
Compatibility of injectable pantoprazole in Y-site administration.
Pharmactuel 2004 ; 37: 193-196.
2150 Noviny Soli M, Bertaccini A, carparelli F, Gotti R, Cavrini V, Andrisano V, Martorana G.
Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine.
J Urology 1998 ; 160; 2: 551-555.
2151 Noviny Gatti R, Gotti R, Cavrini V, Soli M, Bertaccini A, Carparelli F.
Stability study of prostaglandin E1 (PGE1) in physiological solutions by liquid chromatography (HPLC).
Int J Pharm 1995 ; 115: 113-117.
3201 Noviny Dice JE.
Physical compatibility of alprostadil with commonly used IV solutions and medications in the neonatal intensive care unit.
J Pediatr Pharmacol Ther 2006 ; 11:233?6.
3448 Noviny Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M.
Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction.
Ann Pharm Fr 2013 ; 71, 5: 358-363.
3761 Kniha Chavan E.
Etude de la stabilité de solutions de prostaglandine E1 à 48 et 72 heures en vue d'une administration parentérale en continu à des patients de néonatalogie.
Master en pharmacie - University of Geneva 2014
3961 Noviny McCluskey S.V,Kirkham K,Munson J.M.
Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers.
Int J Pharm Compound 2017 ; 21, 2: 150-153.
4069 Noviny Palmero D, Chavan E, Berger-Gryllaki M, Tolsa J-F, Di Paolo E, Pannatier A, Henry H, Sadeghipour F.
Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns.
EJHP 2018 ; 25, e2
4389 Noviny Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Pharmactuel 2019 ;52,4:206-213
4491 Noviny De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A.
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
Eur J Pedia 2020
4507 Noviny Ross E, Salinas A, Petty K, Her C, Carpenter J.
Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing.
Am J Health-Syst Pharm 2020 ;77,23:1980-1985
4543 Noviny Senarathna G, Strunk T, Petrovski M, Batty K.
Physical compatibility of pentoxifylline and intravenous medications.
Archives of Disease in Childhood 2018 ;104:292–295.
4570 Noviny Greenhill K, Hornsby E, Gorman G.
Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients.
Pharmaceuticals 2019
4651 Noviny De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A.
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
Eur J Pedia 2021 ;180,1169–1176.

  Mentions Légales